{
    "nct_id": "NCT05787639",
    "official_title": "Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab In Patients With Previously Untreated Locally Advanced, Resectable, HPVOPC (Human Papilloma Virus Oropharynx Cancer)",
    "inclusion_criteria": "* Histologically confirmed diagnosis of Stage I T1-2N1M0 HPVOPC (Human Papilloma Virus Oropharynx Cancer)\n* Amenable to surgical resection\n* Are able to safely receive neoadjuvant radiation and Evorpacept/Pembrolizumab\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "â€¢ Patients with solitary lymph nodes less than 3 cm",
    "miscellaneous_criteria": ""
}